Jonathan Z Long

Title: The Innovative Contributions of Jonathan Z Long

Introduction

Jonathan Z Long is a prominent inventor based in Solana Beach, California. He is known for his significant contributions to the field of biochemistry, particularly in the area of endocannabinoid signaling. His work has implications for treating various medical conditions, including cancer.

Latest Patents

Jonathan Z Long holds a patent for "Methods and compositions related to targeting monoacylglycerol lipase." This invention provides compounds that selectively inhibit monoacylglycerol lipase (MAGL). The invention also outlines methods for using MAGL selective inhibitors to stimulate 2-Arachidonoylglycerol (2-AG) mediated endocannabinoid signaling in vivo. Furthermore, it offers approaches to treat conditions associated with endocannabinoid signaling. Notably, the invention includes methods for treating cancer or inhibiting tumor growth by targeting MAGL with specific inhibitors. Additionally, it provides methods for screening MAGL inhibitors with improved biochemical and pharmaceutical properties. Jonathan Z Long has 1 patent to his name.

Career Highlights

Jonathan Z Long is affiliated with the Scripps Research Institute, where he conducts his research and development. His work at this prestigious institution has allowed him to explore innovative solutions in the field of biochemistry.

Collaborations

Throughout his career, Jonathan has collaborated with notable scientists, including Benjamin F Cravatt and Weiwei Li. These collaborations have further enhanced the impact of his research and inventions.

Conclusion

Jonathan Z Long's innovative work in targeting monoacylglycerol lipase has the potential to revolutionize treatments for various medical conditions, particularly in cancer therapy. His contributions to the field of biochemistry are noteworthy and continue to inspire future research.